Global Clinical Decision Support Systems (CDSS) Market by Delivery Mode (Cloud, Web, On-premise), by Application (Dosing Support, Allery Alert) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Summary of the Report

In 2016, the global market for clinical decision support systems (CDSS), was worth USD 471.96 millions. Market growth is being driven by rising demand for high quality care and reliable technical solutions. The market is also being stimulated by the increasing adoption of information systems in hospitals and other healthcare institutions, as well as positive initiatives taken by many governments around the world.

FDA strictly regulates clinical decision support systems (CDSS). Platforms in development or introduced must meet the FDA and CE Mark requirements. To ensure products' integrity, competitors must also consider non-violation cyber and information technology laws.

The rapid advancements in biotechnology and bioinformatics have led to significant improvements in data storage, management and analytics platforms. Large corporate investments are expected to bring about a lot of innovation in the marketplace. The integration of cloud computing and interoperability platform in different systems will promote seamless functioning and dataflow, which will increase the adoption of CDSS.

There is a substantial potential for future implementation due to the significant increase in hospitals and other healthcare facilities that have adopted various levels and forms of clinical decision support systems. In developed countries, the demand for decision support that is based on real-time information and factual evidence has increased faster than in other regions. CDSS makes it easier to enter physical orders by allowing doctors to choose from the database. The increasing number of patients who visit hospitals and clinics has made it more difficult to manage and maintain data for each patient.

These regions are expected to see a growing focus on precision medicine and quality care, which will also drive revenue generation. Only authorized users can access cloud-based clinical and drug data. Integrating with EHR (Electronic Health Record) increases efficiency in clinical care by reducing time spent searching for clinical records and patient history.

Collaborations between CDSS providers and hospitals have seen a dramatic increase in the last few years. Partnerships are formed between companies to create and update software. Demand will rise further due to government recognition and initiatives to promote adoption of CDSS/EHR systems.

Product Insights

CDSS products can be used as standalone, integrated with EHRs or CPOEs or both. Because of its simplicity and low cost, stand-alone CDSS is popular. It is easy to use in hospitals and other clinical settings, which has led to the highest market share. The market will remain dominated by the standalone segment throughout the forecast period.

Multi-specialty health units are likely to increase awareness and adopt EHR. This will influence the share of CDSS integrated into EHR. The fastest growth is expected to be in clinical decision support systems that are integrated with CPOE. This is due to the adoption of computerized prescription patterns within developed regions.

Application Insights

CDSS gives results that can predict drug interactions and the patient's reaction to receiving a certain dosage. This helps the practitioner make the right decision about treatment. When the system is populated with medical records and patient history, it generates a list of possible options for further medication. Practitioners can also use this information to help them.

It lists possible drug allergies to a specific drug or combination of drugs. It also lists possible drug-drug interactions, which alerts about possible side effects and adverse drug reactions.

CDSS provides patients with reminders for appointments and medication. It also contains clinical guidelines that provide decision support regarding drug dosage and medication.

In 2016, drug allergy alerts dominated this market. Despite the dominance of drug allergy alerts in 2016, drug dosing support is expected see the most rapid growth.

Delivery Mode Insights

CDSS can only be accessed by authorized users via the web, cloud, or hospital/clinic premises. Due to security and privacy concerns, many people prefer to use on-premise delivery systems. They will continue to be the largest revenue generator in the global arena during the forecast period.

With the constant increase in medical data, it has been possible to access a lot more medical information. In the last few years, FDA approvals have increased for new combinations of treatments of complex health conditions like neurodegeneration and cancer. Individual systems find it difficult to store and handle large amounts of data. Cloud delivery is expected to see a rise in demand.

Component Insights

Software, hardware and services provided by the system providers are key components of CDSS. The hardware is a computer and other electronic gadgets that run the software. The software component analyzes data and provides decision support to organizations. Services include maintenance, upgrade, and troubleshooting of both the hardware and the software provided by the provider.

CDSS services will experience lucrative growth over the forecast period. This is due in part to the timely updating of software and knowledge. Premium access to accurate and current data is expensive. This is likely to impact revenue generation in the segment positively.

Regional Insights

In 2016, North America was the dominant market for CDSS. The region's market will continue to grow due to the rising demand for information technology solutions in healthcare. The region's growth is due to technological advances and a growing focus on high-quality healthcare services.

Asia Pacific is expected to grow the fastest due to increased investments in healthcare in countries like Australia, China and India. This market's CAGR is expected to reach 8.0% over the forecast period.

Market Share Insights & Key Companies

There are several companies in the market: McKesson Corporation, Agfa Healthcare; NextGen Healthcare Information Systems. Medical Information Technology Inc.; Carestream Health Inc., AthenaHealth; Philips Healthcare. Wolters Kluwer NU. Cerner Corporation. Siemens Healthineers. To expand their customer base, market players are entering licensing agreements with top hospitals and healthcare organizations. Assistance Publique - Hopitaux de Paris, for example, extended its seven-year-old contract for an additional four years. This contract included the deployment of ORBIS module at all AP-HP hospitals.

Carestream signed a contract in March 2016 with Lawrence Memorial Healthcare New London for its clinical collaboration platform. In February 2016, Philips Healthcare also signed a collaboration agreement with Valdic. This market is expected to grow with more of these partnerships.

Market Report Scope for Clinical Decision Support Systems

The Report Covers Certain Segments

This report provides a forecast of revenue growth at the country and regional level, as well as an analysis of industry trends for each sub-segment from 2013 through 2024. Grand View Research segmented the global market for clinical decision support systems (CDSS), based on product, application, delivery method, component, region, and other criteria.

• Product Outlook (Revenue USD Million, 2013-2024)

  • CDSS Standalone

  • Integrated CPOE and CDSS

  • Integrated E.H.R. CDSS

  • Integrated CDSS with CPOE & E.H.R.

• App Outlook (Revenue USD Million, 2013-2024)

  • Drug-drug interactions

  • Alerts for drug allergy

  • Reminders for clinicians

  • Guidelines for clinical practice

  • Drug dosing support

  • Other

• Delivery Mode Outlook (Revenue USD Million, 2013-2024)

  • Delivery via the Internet

  • Cloud Delivery

  • On Premises Delivery

• Component Outlook (Revenue USD Million, 2013-2024)

  • Hardware

  • Software

  • Services

• Regional Outlook (Revenue USD Million, 2013-2024)

  • North America

    • The U.S.

    • Canada

  • Europe

    • Germany

    • The U.K.

  • Asia Pacific

    • Japan

    • China

  • Latin America

    • Brazil

  • Middle East and Africa (MEA).

    • South Africa

These are the most frequently asked questions about this report

b. Global market for clinical decision support systems was valued at USD 591.44 Million in 2019. It is projected to grow to USD 631.31 Million in 2020.

b. Global clinical decision support system market is expected to grow at 6.4% compound annual growth rate from 2019-2024, to reach USD 790.78 millions by 2024.

b. With a market share of 49.29%, North America dominated clinical decision support system markets in 2019. This can be attributed to technological advances, a growing emphasis on healthcare services quality and a rising demand for information technology solutions in healthcare.

b. b.

b. b. The market is also being stimulated by the increasing adoption of information systems in hospitals and other healthcare institutions, as well as favorable initiatives taken worldwide by many governments.

Up Market Research published a new report titled “Clinical Decision Support Systems (CDSS) Market research report which is segmented by Delivery Mode (Cloud, Web, On-premise), by Application (Dosing Support, Allery Alert), By Players/Companies Agfa Healthcare; McKesson Corporation; NextGen Healthcare Information Systems; Medical Information Technology Inc; Carestream Health Inc; AthenaHealth; Philips Healthcare; Wolters Kluwer NU; Cerner Corporation; and Siemens Healthineers”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Clinical Decision Support Systems (CDSS) Market Report Segments:

The market is segmented by Delivery Mode (Cloud, Web, On-premise), by Application (Dosing Support, Allery Alert).

Clinical Decision Support Systems (CDSS) Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Clinical Decision Support Systems (CDSS) Market

Overview of the regional outlook of the Clinical Decision Support Systems (CDSS) Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Clinical Decision Support Systems (CDSS) Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Clinical Decision Support Systems (CDSS) Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. Cloud

                2. Web

                3. On-premise

                1. Dosing Support

                2. Allery Alert

8. Market scenario by region, sub-region, and country.
9. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
10. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
11. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Clinical Decision Support Systems (CDSS) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Clinical Decision Support Systems (CDSS) Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.